Learn about the CABLIVI Patient Solutions Copay Assistance Program for Commercially Insured Patients

Terms and restrictions apply

CABLIVI is the first and only FDA-approved treatment for adults with aTTP/iTTP in combination with plasma exchange and immunosuppression.

Are you or a loved one in the hospital with aTTP/iTTP?
 

An aTTP/iTTP episode can be overwhelming
 

CABLIVI treatment starts in the hospital and continues at home

What is CABLIVI?

CABLIVI is the first and only FDA-approved treatment for aTTP/iTTP in combination with plasma exchange and immunosuppression.

The science of CABLIVI

Discover how CABLIVI was designed to help take on aTTP/iTTP and work with plasma exchange and immunosuppression.

CABLIVI Patient Solutions

Our support program is with you from hospital to home to help provide financial assistance for eligible patients, education, and more.

*aTTP is also known as iTTP. You and your healthcare team can use either term.
aTTP/iTTP=acquired/immune-mediated thrombotic thrombocytopenic purpura; FDA=Food and Drug Administration.

IMPORTANT SAFETY INFORMATION AND INDICATIONS